Literature DB >> 30563304

Targeting microRNAs using nanotechnology in pulmonary diseases.

Kamal Dua1,2,3, Dinesh K Chellappan4, Gautam Singhvi5, Terezinha de Jesus Andreoli Pinto6, Gaurav Gupta7, Philip M Hansbro8,9,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30563304     DOI： 10.23736/S0031-0808.18.03459-6

Source DB:  PubMed          Journal:  Panminerva Med        ISSN： 0031-0808            Impact factor:   5.197


× No keyword cloud information.
  3 in total

1.  Clinical value of serum miR-92 and miR-122 expression level combined with pulmonary ultrasound score in the prognosis of neonatal acute respiratory distress syndrome.

Authors:  Haiyan Hong; Binbin Fu; Renyuan Wang
Journal:  J Clin Lab Anal       Date:  2022-05-25       Impact factor: 3.124

2.  miRNA nanotherapeutics: potential and challenges in respiratory disorders.

Authors:  Meenu Mehta; Dinesh K Chellappan; Peter R Wich; Nicole G Hansbro; Philip M Hansbro; Kamal Dua
Journal:  Future Med Chem       Date:  2020-04-09       Impact factor: 3.808

3.  Prognostic value of pulmonary ultrasound score combined with plasma miR-21-3p expression in patients with acute lung injury.

Authors:  Renyang Liu; Guoxu Zhao; Qinyu Wang; Fangxiao Gong
Journal:  J Clin Lab Anal       Date:  2022-02-10       Impact factor: 2.352
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.